Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|February 5, 2014
Enobosarm (GTx-024, S-22): a potential treatment for cachexiaReshmi Srinath, Adrian Dobs
American Journal of Lifestyle Medicine|January 17, 2025
The Impact of Physical Activity in Patients With Type 2 DiabetesSandhya Rao Bassin, Reshmi Srinath
Current Opinion in Clinical Nutrition and Metabolic Care|February 1, 2020
Dietary management of blood glucose in medical critically ill patients with overweight/obesityReshmi Srinath, Jeffrey I Mechanick
American Journal of Lifestyle Medicine|March 8, 2023
The Negative Impact of Routine, Dietary Pattern, and Physical Activity on Obesity and Dysglycemia During the COVID-19 PandemicJustina L Ray, Reshmi Srinath, Jeffrey I Mechanick
The Journal of Clinical Endocrinology and Metabolism|January 14, 2015
Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities studyReshmi Srinath, Sherita Hill Golden, Kathryn A Carson, et al.
Stroke|October 13, 2016
Association Between Endogenous Testosterone and Cerebrovascular Disease in the ARIC Study (Atherosclerosis Risk in Communities)Reshmi Srinath, Rebecca F Gottesman, Sherita Hill Golden, et al.
American Journal of Preventive Cardiology|April 20, 2026
Shifts in body mass index category with tirzepatide and associated changes in cardiometabolic risk factors in people with obesity: a post hoc analysis from the SURMOUNT-1 and SURMOUNT-4 trialsNaveed Sattar, Clare J Lee, Reshmi Srinath, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 16, 2025
American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 UpdateKarl Nadolsky, W Timothy Garvey, Monica Agarwal, et al.
Lancet (London, England)|May 12, 2026
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trialDeborah B Horn, Louis J Aronne, Sean Wharton, et al.
Pageof 1